Rugiet, a men's health company, today announced the launch of its testosterone replacement therapy (TRT), marking a significant expansion beyond its flagship erectile dysfunction ...
Add Yahoo as a preferred source to see more of our stories on Google. Erectile dysfunction can cause a “self-perpetuating cycle of anxiety and performance pressure,” says one expert. (Photo ...
It’s no surprise that many people are uncomfortable talking to a doctor about erectile dysfunction. The shame and embarrassment that people with this condition often feel can affect relationships, ...
Many healthcare professionals recommend that people with both conditions take steps to improve ED first, before undergoing treatment specifically for Peyronie disease. Still, some treatments for ...
Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted ...
An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.
Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up to date, and accurate.
Erectile dysfunction can indicate heart disease years before cardiovascular issues arise. In fact, most heart problems don’t ...
KNOXVILLE, Tenn. — Vincent Martin is like millions of men across the globe who struggle with erectile dysfunction. It's a topic many won't speak up about. However, Martin is ready to be heard. He ...
A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells, known as aquablation, could prevent incontinence as well as erectile dysfunction, ...
Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted an application to the UK’s Medicine ...